University Cancer Research Fund Enables Innovative Solutions to Complex Problems
Kaposi sarcoma-associated herpesvirus produces a protein that blocks the cell's inflammatory response
Researchers investigating a genetic mutation in brain cancer and leukemia patients have discovered how one cancer metabolite battles another normal metabolite to contribute cancer development. Helping the “good guys” win that battle could yield new approaches for treatment.
C. elegans model shows how RAS oncogene switching determines a cell's fate
Heartfelt thanks to the staff of the N.C. Cancer Hospital, fellow UNC employees, our volunteers, patients, families, and friends. The Oncology Winter Coat Drive was a tremendous success - 107 winter coats were collected and distributed to our families and their caregivers throughout the month of January until February 11, 2011. Hats, scarves, gloves, and socks were added to each winter coat selection as needed. A very special Valentine’s Day thank you to all for sharing your hearts!
An Interview With Oncology Clinical Pharmacist John Valgus, PharmD, BCOP, CPP
UNC Lineberger Primary Benefactor for the Wachovia Tar Heel 10 Miler - Chapel Hill's Largest Running Event
Technology developed by UNC Lineberger members may lead to diagnostic test
Resulting Database to Yield Big Gains for Genetic Scientists
Normal humans produce a novel, circular form of non-coding RNA that regulates aging
UNC Hospitals is one of 378 facilities in the world, and among only 6 percent of all U.S. hospitals, that have earned Magnet designation.
Organization will receive The Artist in Residence Program to help people affected by cancer
G-Zero Therapeutics funded under Qualifying Therapeutic Discovery Project
Cell signaling protein may hold key to blocking long-studied genetic mutation
In a study published this month in the Journal of Clinical Oncology, the results of a clinical trial of the drug bevacizumab to treat colon cancer in combination with the standard therapy found that the drug did not significantly increase disease-free survival in patients with stage II and stage III colon cancer.
$11.9 Million in awards to address cancer disparities
N.C. native John Isner and doubles partner Sam Querrey to host
ABC Anchor Robin Roberts Guest of Honor at Kickoff Event
Project Focuses on Efficient, Low-Cost Genetic Analysis
UNC Scientists Receive Grant to Develop Nanotechnology for Pancreatic Cancer Diagnosis and Treatment
National Cancer Institute awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence
The article "How Old Are You, Really?" written by Mark Derewicz and published in the Fall 2010 issue of Endeavors magazine features UNC Lineberger member Ned Sharpless, MD. Dr. Sharpless is an associate professor of medicine and genetics and associate director for translational research at UNC Lineberger.
Part of UNC Comprehensive Cancer Support Program
UNC Lineberger team will examine minority, underserved populations
Hearing of the House Energy and Commerce Committee's Subcommittee on Oversight and Investigations, July 20, 2010
UNC researchers reveal how a protein called Tet1 helps stem cells keep their “stemness” in a paper published in Nature.
UNC's Goldberg a Key Contributor
This news story was originally published on June 17, 2010 by Campbell University. Reprinted with permission
Nancy Thomas, MD, PhD, Co-Director of UNC’s Interdisciplinary Melanoma Program, talks about sun safety and early detection of skin cancer
Evans is director of clinical cancer genetics at UNC Lineberger. Article originally published in the June 27, 2010 issue of Newsday.
Discovery has potential for cancer patients and disaster victims
Strategic Partnership to Advance Nanotechnology-Based Diagnosis and Treatment
UNC Lineberger Genetics Policy, Law, Medicine Expert Discusses March 29, 2010 US District Court Gene Patenting Ruling
Group Received ASCO 2010 Clinical Trial Participation Award
James Bear PhD, and Klaus Hahn, PhD, Directors
UNC-developed technique has broad applications in cancer, biomedical research
Program brings top cancer expertise to the Outer Banks
Local Group Bikes Across the Country to Raise Money for UNC Lineberger
Jean and Woody Durham Honored with Service Award from UNC Lineberger Comprehensive Cancer Center in Chapel Hill
Findings may illuminate how cancer forms and migrates
Findings have potential for cancer, other age-related diseases
QUANTEC review replaces 20-year old guidelines
This profile is part of a series highlighting how UNC Lineberger and the UNC School of Medicine are shaping the next generation of cancer researchers and physicians
Join the National Marrow Donor Program’s registry and you could save a life!
Study from The Cancer Genome Atlas an important step towards personalized therapy
Jean Sellers, RN, MSN, OCN, Talks about Helping Patients Cope Financially in the Latest Issue of ONS Connect
UNC Lineberger Comprehensive Cancer Center a Beneficiary
National effort will shape the future of cancer research and treatment
Chapel Hill, NC - A disagreement between Nancy Allbritton, MD, PhD and David Lawrence, PhD over which cancer - breast or prostate - should be the higher priority in their partnership resulted in two successful NIH grant proposals. Lawrence is taking the lead on a prostate cancer grant while Allbritton leads a breast cancer grant – totaling almost $5 million over the next five years.
Chapel Hill, NC - Hyman B. Muss, MD, has joined the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill School of Medicine. Muss will be a professor of medicine and will develop and lead a new program in geriatric oncology.
Members of the NC General Assembly are touring the North Carolina Cancer Hospital to get an early view of the state’s new state-of-the-art facility. Greeted by UNC-Chapel Hill Chancellor Holden Thorp and UNC School of Medicine Dean Bill Roper, the legislators visited several key locales in the building that will improve the way cancer care is delivered at UNC and across North Carolina
CHAPEL HILL –Dr. Shelley Earp, UNC Lineberger director, was invited to address the NC Senate Science and Technology Committee to talk about UNC and the Lineberger Comprehensive Cancer Center as the state’s Center of Excellence in Cancer Research.
Dr. Kimberly Kasow joins UNC School of Medicine Department of Pediatrics to lead pediatric bone marrow transplantation program
Chapel Hill, NC - Kimberly Kasow, DO, has joined the University of North Carolina at Chapel Hill as director of the UNC Pediatric Bone Marrow Transplantation program. Kasow is an associate professor of pediatrics and a member of the UNC Lineberger Comprehensive Cancer Center.
UNC study: New genomic test may guide breast cancer treatment choices
Donald L. Rosenstein joins UNC Lineberger Comprehensive Cancer Center to lead new cancer support program
Chapel Hill, NC - Donald L. Rosenstein, MD, joins the University of North Carolina's Lineberger Comprehensive Cancer Center as Director of the new UNC Comprehensive Cancer Support Program.
On June 20, Dr. Lisa Carey, medical director of the UNC Breast Center, gave a talk on “Everything You Always Wanted to Know about Breast Cancer But Were Afraid to Ask” in Dare County. This inaugural “Lunch & Learn” was held in the Cancer Resource Center of the Outer Banks Hospital with an at-capacity crowd of 40 people.
On Friday, June 6th, the UNC Specialty Clinic opened its doors to patients in Dare County and the surrounding areas. Dr. Thomas Shea, UNC Lineberger Comprehensive Cancer Center associate director of clinical outreach, and Jean Sellers, RN, oncology program manager traveled to Nag’s Head for the first day of clinic operations.
University Cancer Research Fund Grant Teams Lineberger Faculty with Renaissance Computing Institute to Battle Skin Cancer
CHAPEL HILL, NC - A new collaboration between melanoma researchers in the School of Medicine at the University of North Carolina at Chapel Hill, the Renaissance Computing Institute (RENCI), and researchers from the departments of computer science, epidemiology, biostatistics, and statistics and operations research at UNC Chapel Hill aims to use image analysis techniques to aid doctors in the fight against melanoma, the most serious form of skin cancer.
CHAPEL HILL - Fred Eshelman, chief executive officer and founder of Wilmington-based PPD Inc., has pledged $9 million to support cancer research at the School of Pharmacy at the University of North Carolina at Chapel Hill.
CHAPEL HILL - The University of North Carolina’s two medical schools and their cancer centers have signed a memorandum of understanding that creates a partnership to advance cancer research and bring leading-edge treatment to North Carolinians.
CHAPEL HILL – The governance committee of the University Cancer Research Fund has established first-year spending priorities for the state’s initial $25 million investment at the University of North Carolina at Chapel Hill.
Stephen Frye, PhD, former worldwide head of discovery medicinal chemistry at GlaxoSmithKline, will lead the new Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill.
Winston-Salem Journal Editorial, August 8, 2007
Editorials, Charlotte Observer, August 3, 2007
Funding will improve quality of life for cancer patients, families statewide